EP2760843 - SELECTIVE NR2B ANTAGONISTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.01.2017 Database last updated on 06.07.2024 | Most recent event Tooltip | 12.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [2016/09] |
Former [2014/32] | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 05843-4000 / US | Inventor(s) | 01 /
KING, Dalton c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 02 /
MACOR, John E. c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 03 /
OLSON, Richard E. c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 04 /
IWUAGWU, Christiana I. c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 05 /
KARAGEORGE, George N. c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | [2014/32] | Representative(s) | Vögeli-Lange, Regina, et al Swords Laboratories Swiss Branch, Steinhausen Hinterbergstrasse 16 6330 Cham / CH | [2016/09] |
Former [2014/32] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 12766843.2 | 24.09.2012 | [2016/09] | WO2012US56860 | Priority number, date | US201161539113P | 26.09.2011 Original published format: US 201161539113 P | [2014/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2013048949 | Date: | 04.04.2013 | Language: | EN | [2013/14] | Type: | A2 Application without search report | No.: | EP2760843 | Date: | 06.08.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.04.2013 takes the place of the publication of the European patent application. | [2014/32] | Type: | B1 Patent specification | No.: | EP2760843 | Date: | 02.03.2016 | Language: | EN | [2016/09] | Search report(s) | International search report - published on: | EP | 18.07.2013 | Classification | IPC: | C07D239/42, C07D401/12, C07D403/12, C07D413/12, C07D417/12, C07D471/04, A61K31/444, A61P25/00 | [2014/32] | CPC: |
C07D401/12 (EP,US);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
C07D239/42 (EP,US);
C07D403/12 (EP,US);
C07D413/12 (EP,US);
C07D417/12 (EP,US);
C07D471/04 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/32] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | SELEKTIVE NR2B-ANTAGONISTEN | [2014/32] | English: | SELECTIVE NR2B ANTAGONISTS | [2014/32] | French: | ANTAGONISTES DU NR2B SÉLECTIFS | [2014/32] | Entry into regional phase | 25.04.2014 | National basic fee paid | 25.04.2014 | Designation fee(s) paid | 25.04.2014 | Examination fee paid | Examination procedure | 25.04.2014 | Examination requested [2014/32] | 24.11.2014 | Amendment by applicant (claims and/or description) | 07.07.2015 | Communication of intention to grant the patent | 29.10.2015 | Fee for grant paid | 29.10.2015 | Fee for publishing/printing paid | 29.10.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.07.2015 | Opposition(s) | 05.12.2016 | No opposition filed within time limit [2017/06] | Fees paid | Renewal fee | 12.09.2014 | Renewal fee patent year 03 | 11.09.2015 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 24.09.2012 | AL | 02.03.2016 | AT | 02.03.2016 | BE | 02.03.2016 | CY | 02.03.2016 | CZ | 02.03.2016 | DK | 02.03.2016 | EE | 02.03.2016 | ES | 02.03.2016 | FI | 02.03.2016 | HR | 02.03.2016 | IT | 02.03.2016 | LT | 02.03.2016 | LV | 02.03.2016 | MC | 02.03.2016 | MK | 02.03.2016 | NL | 02.03.2016 | PL | 02.03.2016 | RO | 02.03.2016 | RS | 02.03.2016 | SE | 02.03.2016 | SI | 02.03.2016 | SK | 02.03.2016 | SM | 02.03.2016 | TR | 02.03.2016 | BG | 02.06.2016 | NO | 02.06.2016 | GR | 03.06.2016 | IS | 02.07.2016 | PT | 04.07.2016 | IE | 24.09.2016 | LU | 24.09.2016 | CH | 30.09.2016 | LI | 30.09.2016 | MT | 30.09.2016 | [2018/46] |
Former [2018/45] | HU | 24.09.2012 | |
AT | 02.03.2016 | ||
BE | 02.03.2016 | ||
CY | 02.03.2016 | ||
CZ | 02.03.2016 | ||
DK | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
MC | 02.03.2016 | ||
MK | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SI | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
TR | 02.03.2016 | ||
BG | 02.06.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
IE | 24.09.2016 | ||
LU | 24.09.2016 | ||
CH | 30.09.2016 | ||
LI | 30.09.2016 | ||
MT | 30.09.2016 | ||
Former [2018/31] | HU | 24.09.2012 | |
AT | 02.03.2016 | ||
BE | 02.03.2016 | ||
CY | 02.03.2016 | ||
CZ | 02.03.2016 | ||
DK | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
MC | 02.03.2016 | ||
MK | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SI | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
BG | 02.06.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
IE | 24.09.2016 | ||
LU | 24.09.2016 | ||
CH | 30.09.2016 | ||
LI | 30.09.2016 | ||
MT | 30.09.2016 | ||
Former [2018/28] | HU | 24.09.2012 | |
AT | 02.03.2016 | ||
BE | 02.03.2016 | ||
CZ | 02.03.2016 | ||
DK | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
MC | 02.03.2016 | ||
MK | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SI | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
BG | 02.06.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
IE | 24.09.2016 | ||
LU | 24.09.2016 | ||
CH | 30.09.2016 | ||
LI | 30.09.2016 | ||
Former [2017/41] | AT | 02.03.2016 | |
BE | 02.03.2016 | ||
CZ | 02.03.2016 | ||
DK | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
MC | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SI | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
BG | 02.06.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
IE | 24.09.2016 | ||
LU | 24.09.2016 | ||
CH | 30.09.2016 | ||
LI | 30.09.2016 | ||
Former [2017/31] | AT | 02.03.2016 | |
BE | 02.03.2016 | ||
CZ | 02.03.2016 | ||
DK | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
MC | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SI | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
BG | 02.06.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
Former [2017/16] | AT | 02.03.2016 | |
BE | 02.03.2016 | ||
CZ | 02.03.2016 | ||
DK | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SI | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
BG | 02.06.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
Former [2017/07] | AT | 02.03.2016 | |
BE | 02.03.2016 | ||
CZ | 02.03.2016 | ||
DK | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
Former [2017/03] | AT | 02.03.2016 | |
BE | 02.03.2016 | ||
CZ | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
IT | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
Former [2016/51] | AT | 02.03.2016 | |
CZ | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
PT | 04.07.2016 | ||
Former [2016/50] | AT | 02.03.2016 | |
CZ | 02.03.2016 | ||
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RO | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
SK | 02.03.2016 | ||
SM | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
Former [2016/49] | AT | 02.03.2016 | |
EE | 02.03.2016 | ||
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
Former [2016/48] | AT | 02.03.2016 | |
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
IS | 02.07.2016 | ||
Former [2016/40] | AT | 02.03.2016 | |
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
NL | 02.03.2016 | ||
PL | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
Former [2016/39] | AT | 02.03.2016 | |
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
LT | 02.03.2016 | ||
LV | 02.03.2016 | ||
PL | 02.03.2016 | ||
RS | 02.03.2016 | ||
SE | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
Former [2016/36] | AT | 02.03.2016 | |
ES | 02.03.2016 | ||
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
LT | 02.03.2016 | ||
PL | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | ||
Former [2016/35] | ES | 02.03.2016 | |
FI | 02.03.2016 | ||
HR | 02.03.2016 | ||
NO | 02.06.2016 | ||
GR | 03.06.2016 | Cited in | International search | [A]WO0132174 (MERCK & CO INC [US], et al) [A] 1-11 * page 1; example 55; claims 1,11 *; | [X]US2004053908 (FUNAHASHI YASUHIRO [JP], et al) [X] 1,4,5,7 * examples 568-2 *; | [A]US2004204341 (ALLEN CHRISTOPHER [US], et al) [A] 1,2,4-11 * compounds 30,34,44-47,57,62,76 *; | [X]US2005245530 (BORZILLERI ROBERT M [US], et al) [X] 1,4,5,7 * compound 28 on page 10;; examples 11C,14C,22B,22C,28C,31C *; | [Y]WO2006017409 (MERCK & CO INC [US], et al) [Y] 1-11* page 1; examples 49,50; claim 11 *; | [X]US2006128734 (FLOERSHEIMER ANDREAS [CH], et al) [X] 1,2,4-7 * example 47.1k *; | [X]US2008090856 (FLYNN DANIEL L [US], et al) [X] 1,4,5,7 * A39 on page 41 *; | [X]US2008255155 (RAEPPEL STEPHANE [CA], et al) [X] 1,4,5,7 * compounds 60,64,69 *; | [X]US2008312192 (BOLD GUIDO [CH], et al) [X] 1,4,5,7 * compound 55c.1b;85.1 *; | [X]US2009149467 (DINSMORE CHRISTOPHER J [US], et al) [X] 1,4,7 * claim 1; compounds 2,5,6,14-19,20,21 *; | [X]WO2009091388 (PROGENICS PHARM INC [US], et al) [X] 1,5,7 * page 345, entry 9;; claim 1 *; | [Y]WO2009104990 (OBSCHESTVO S OGRANICHENNOI OTV [RU], et al) [Y] 1-11 * the whole document *; | [X]US2010029610 (SINGH JUSWINDER [US], et al) [X] 1,4,5,7 * paragraph [1016] *; | [X]US2010190804 (COMBS ANDREW PAUL [US], et al) [X] 1-5,7 * Formula 4-3a on page 44; paragraphs [0687] , [0709] , [0779] , [0791] *; | [X]EP2325175 (ASTELLAS PHARMA INC [JP]) [X] 1,4,5,7 * page 114; example 175; claim 1 *; | [XP]WO2011140338 (GATEKEEPER PHARMACEUTICALS INC [US], et al) [XP] 1 * compound 8 on page 53 *; | [Y] - WERMUTH C G, "MOLECULAR VARIATIONS BASED ON ISOSTERIC REPLACEMENTS", PRACTICE OF MEDICINAL CHEMISTRY, XX, XX, (1996), pages 203 - 237, XP002190259 [Y] 1-11 * pages 209,211 * | by applicant | WO2009006437 | - G. SANACORA, NATURE REV. DRUG DISC., (2008), vol. 7, pages 426 - 437 | - ZARATE ET AL., ARCH. GEN. PSYCHIATRY, (2006), vol. 63, pages 856 - 864 | - PRESKOM ET AL., J. CLIN. PSYCHOPHARMACOL., (2008), vol. 28, pages 631 - 637 | - F. S. MENNITI ET AL., CNS DRUG REVIEWS, (1998), vol. 4, no. 4, pages 307 - 322 |